About William Chamberlin
William Chamberlin is CEO and director at Protibea Therapeutics.
William Chamberlin first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name William Chamberlin in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Chamberlin works with at each company, as listed on that company's latest Form D.
Protibea Therapeutics, Inc. · Form D, Aug 18, 2025